Reduction labioplasty for hypertrophic labia minora is often performed for aesthetic reasons by cosmetic vaginal surgeons. However, hypertrophy of the labia minora can also result in significant morbidity because it causes physical discomfort during activity and interferes with the ability to maintain local hygiene and perform intermittent self-catheterization in certain patients.
We describe a case in which a commonly used technique for reduction labioplasty was performed on a patient who had difficulty performing intermittent catheterization and report on the aesthetic and functional outcomes.
A linear resection labioplasty was performed in a 13-year-old girl who was having increasing difficulty performing intermittent self-catheterization because of redundant labial tissue. She was also developing frequent recurrent urinary tract infections thought to be secondary to difficulty maintaining local hygiene and reduced compliance with her intermittent catheterization regimen.
An excellent cosmetic and functional result was achieved with the procedure. Comparison of preoperative and postoperative photographs demonstrates the extent of the reduction labioplasty. The patient has not had any more difficulty with catheterization or recurrent urinary tract infections in 30 months of follow-up.
Reduction labioplasty is indicated for hypertrophic labia minora for more than aesthetic reasons. We describe a case in which the procedure allowed the patient to more easily perform intermittent catheterization and helped eliminate her recurrent urinary tract infections.
Patients with redundant labial tissue presenting with recurrent urinary tract infection can be managed with reduction labioplasty.
From the *Department of Urology, Stanford University School of Medicine, Stanford, CA; and †Division of Urology and ‡Division of Plastic and Reconstructive Surgery, National Institute for Rehabilitation, Provincia de Buenos Aires, Argentina.
Reprints: Jonathan A. Wu, MD, Department of Urology, Stanford University School of Medicine, 300 Pasteur Dr, RM S287, Stanford, CA 94305-5118. E-mail: Jonathan.email@example.com.
Dr Comiter is a paid consultant for Coloplast and Curant. All other authors do not have any conflict of interest disclosures.
Jonathan A. Wu and Emmanuel J. Braschi contributed equally to this work.